Christopher James Lord

1 Patent

• US122330602025

  Inhibitors of Ataxia-telangiectasia Mutated and Rad3-related Protein Kinase (ATR) for Use in Methods of Treating Cancer

  BREAST CANCER NOW

  0 cites